The ensuing immune reconstitution associated with the cessation of anti-TNFα, coupled with the propensity for disseminated TB manifestations, creates increased susceptibility in patients to the potential onset of immune reconstitution inflammatory syndrome (IRIS), a phenomenon that can exhibit varying degrees of clinical severity [11, 12]. Here, TNF is linked to tuberculosis.